Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:XLRN

Acceleron Pharma (XLRN) Stock Price, News & Analysis

Acceleron Pharma logo

About Acceleron Pharma Stock (NASDAQ:XLRN)

Advanced Chart

Key Stats

Today's Range
$178.75
$178.75
50-Day Range
$172.08
$179.68
52-Week Range
$108.82
$189.99
Volume
N/A
Average Volume
572,759 shs
Market Capitalization
$10.93 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive XLRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acceleron Pharma and its competitors with MarketBeat's FREE daily newsletter.

XLRN Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
Acceleron Banks on Muons for Colder Fusion
ORBIMED CAPITAL GP II LLC's Net Worth
XLRN Historical Data
See More Headlines

XLRN Stock Analysis - Frequently Asked Questions

Acceleron Pharma Inc. (NASDAQ:XLRN) released its quarterly earnings results on Thursday, November, 4th. The biopharmaceutical company reported ($1.16) earnings per share for the quarter, missing analysts' consensus estimates of ($0.98) by $0.18. Acceleron Pharma's revenue for the quarter was up 51.6% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Acceleron Pharma investors own include Bristol Myers Squibb (BMY), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Meta Platforms (META), Pfizer (PFE), NVIDIA (NVDA) and Vertex Pharmaceuticals (VRTX).

Company Calendar

Last Earnings
11/04/2021
Today
7/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:XLRN
CIK
1280600
Employees
312
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$166.03 million
Net Margins
-226.01%
Pretax Margin
-225.99%

Debt

Sales & Book Value

Annual Sales
$92.52 million
Price / Cash Flow
N/A
Book Value
$11.74 per share
Price / Book
15.23

Miscellaneous

Free Float
60,116,000
Market Cap
$10.93 billion
Optionable
Optionable
Beta
0.13

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:XLRN) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners